Biosimilar Purification with Ion Exchange and Mixed-Mode Resins
Presented by: Randy Drevland, PhD, Senior Applications Scientist
View on demand
Dr. Drevland presents a viable alternative workflow for the development of a HUMIRA-like biosimilar using IEX and mixed-mode resins.
The Ups and Downs of Biosimilar Development
In this podcast, biosimilar key opinion leader Dr. Paul Rhyne provides an overview of the current state of biosimilars and their global impact. Leveraging his 20+ years of experience in developing biologics, he discusses how cost and patient access play a big role in this new field of research.